The metabolic syndrome in cancer survivors.

[1]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[2]  A. Koivisto,et al.  Obesity and metabolic changes are common in young childhood brain tumor survivors , 2009, Pediatric blood & cancer.

[3]  Mimi Y. Kim,et al.  A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.

[4]  John D Boice,et al.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Green,et al.  Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Ness,et al.  Physical performance limitations in the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Coebergh,et al.  Survival of European children and young adults with cancer diagnosed 1995-2002. , 2009, European journal of cancer.

[8]  R. Storb,et al.  Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. , 2009, Blood.

[9]  J. Svartberg,et al.  Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men. , 2008, International journal of andrology.

[10]  Aldons J. Lusis,et al.  Metabolic syndrome: from epidemiology to systems biology , 2008, Nature Reviews Genetics.

[11]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[12]  S. Tonstad,et al.  Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). , 2008, Gynecologic oncology.

[13]  A. Zietman,et al.  Metabolic changes during gonadotropin‐releasing hormone agonist therapy for prostate cancer , 2008, Cancer.

[14]  M. Baldini,et al.  Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation , 2008, Bone Marrow Transplantation.

[15]  S. Grundy.  Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  W. Kamps,et al.  Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. , 2008, The Lancet. Oncology.

[17]  S. Fosså,et al.  Long term physical sequelae after adult-onset cancer , 2008, Journal of cancer survivorship : research and practice.

[18]  S. Steinberg,et al.  Metabolic syndrome traits in long‐term survivors of pediatric sarcoma , 2008, Pediatric blood & cancer.

[19]  P. Stattin,et al.  Components of the metabolic syndrome and colorectal cancer risk; a prospective study , 2008, International Journal of Obesity.

[20]  R. Ross,et al.  Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[22]  U. Saarinen-Pihkala,et al.  Insufficient Growth Hormone Secretion is Associated With Metabolic Syndrome After Allogeneic Stem Cell Transplantation in Childhood , 2007, Journal of pediatric hematology/oncology.

[23]  G. Mancia,et al.  The sympathetic nervous system and the metabolic syndrome. , 2007, Journal of hypertension.

[24]  I. Papassotiriou,et al.  Early Indicators of Dysmetabolic Syndrome in Young Survivors of Acute Lymphoblastic Leukemia in Childhood as a Target for Preventing Disease , 2007, Journal of pediatric hematology/oncology.

[25]  H. Bartelink,et al.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.

[26]  B. Wolffenbuttel,et al.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  S. Lewis.  Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women? , 2007, American heart journal.

[28]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[29]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[30]  R. Hardy,et al.  The metabolic syndrome: A high-risk state for cancer? , 2006, The American journal of pathology.

[31]  S. Fosså,et al.  Components of the metabolic syndrome in long-term survivors of testicular cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  Kevin C Oeffinger,et al.  Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.

[33]  K. Ness,et al.  Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia , 2006, Cancer.

[34]  A. Dobs,et al.  Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[36]  B. Ahrén,et al.  Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. , 2006, The Journal of clinical endocrinology and metabolism.

[37]  M. Vance,et al.  CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline , 2006 .

[38]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[39]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[40]  P. Savage,et al.  Magnesium Intake and Incidence of Metabolic Syndrome Among Young Adults , 2006, Circulation.

[41]  S. Grundy.  Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy , 2006, Nature Reviews Drug Discovery.

[42]  G. Reaman,et al.  Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation , 2006, Pediatric blood & cancer.

[43]  A. Smit,et al.  Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[45]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[46]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[47]  A. Tragiannidis,et al.  Metabolic Syndrome in Children and Adolescents With Acute Lymphoblastic Leukemia After the Completion of Chemotherapy , 2005, Journal of pediatric hematology/oncology.

[48]  S. Lipshultz,et al.  Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and prevention , 2005, Pediatric blood & cancer.

[49]  A. Smit,et al.  The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer , 2005 .

[50]  P. Ganz,et al.  Obesity and Cardiovascular Risk Factors in Younger Breast Cancer Survivors: The Cancer and Menopause Study (CAMS) , 2005, Breast Cancer Research and Treatment.

[51]  K. Ness,et al.  Body mass index in long‐term adult survivors of childhood cancer , 2005, Cancer.

[52]  R. Lewensohn,et al.  Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[53]  L. Robison,et al.  Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[55]  C. Blomqvist,et al.  Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids , 2004, British Journal of Cancer.

[56]  L. Niskanen,et al.  Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. , 2004, Diabetes care.

[57]  A. V. van Roon,et al.  Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. , 2004, European journal of cancer.

[58]  N. Secher,et al.  Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin , 2003, British Journal of Cancer.

[59]  Richard Hellman,et al.  American College of Endocrinology position statement on the insulin resistance syndrome. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[60]  K. Ness,et al.  Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. , 2003, The Journal of clinical endocrinology and metabolism.

[61]  S. Fosså,et al.  The level of physical activity in long-term survivors of testicular cancer. , 2003, European journal of cancer.

[62]  M. C. Carr,et al.  The emergence of the metabolic syndrome with menopause. , 2003, The Journal of clinical endocrinology and metabolism.

[63]  D P Dearnaley,et al.  Cardiovascular disease as a long-term complication of treatment for testicular cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  T. Fears,et al.  Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  M. Secic,et al.  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. , 2001, Cancer.

[66]  M. Parmar,et al.  The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. , 2001, The Journal of clinical endocrinology and metabolism.

[67]  J. Radford,et al.  Randomized placebo‐controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy , 2001, Clinical endocrinology.

[68]  N. Skakkebaek,et al.  Gonadal status in male survivors following childhood brain tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[69]  E. Winer,et al.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  U. Saarinen-Pihkala,et al.  Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood , 2000, The Lancet.

[71]  D. Green,et al.  Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. , 2000, The Journal of clinical endocrinology and metabolism.

[72]  M. Ranke,et al.  Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood , 2000, Hormone Research in Paediatrics.

[73]  J. Radford,et al.  The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition , 2000, Clinical endocrinology.

[74]  E. Fliers,et al.  Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease , 2000, Cancer.

[75]  D J van Veldhuisen,et al.  Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[77]  Brennan,et al.  Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? , 1999, Clinical endocrinology.

[78]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[79]  J. Warner,et al.  Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy , 1997 .

[80]  M. Knip,et al.  Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[81]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[82]  C. Bailey,et al.  New Drugs for Type 2 Diabetes Mellitus , 2012, Drugs.

[83]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[84]  N. Tritos,et al.  Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. , 2009, The Journal of clinical endocrinology and metabolism.

[85]  K. Ness,et al.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.

[86]  S. Shalet,et al.  Hypopituitarism following radiotherapy , 2008, Pituitary.

[87]  A. von Eckardstein,et al.  The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men , 2002, Diabetologia.

[88]  G. Reaven.  Banting lecture 1988 , 1997 .